Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Pharmaceutical Lin-Gang is a strategic subsidiary and high-end manufacturing base of Shanghai Pharmaceuticals Holding Co., Ltd., located in the Lin-Gang Special Area of the Shanghai Free Trade Zone. The facility serves as a flagship industrialization hub designed to bridge the gap between innovative drug R&D and large-scale commercial production. It focuses on the manufacturing of advanced biologics, vaccines, and high-end chemical formulations, utilizing automated and intelligent production systems. As a key participant in the "Life Blue Bay" biopharmaceutical cluster, the company supports the parent organization's extensive pipeline while also offering CDMO services to external partners. The establishment of this base is a central component of Shanghai Pharma's long-term strategy to enhance its domestic and global competitiveness in innovative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Pharmaceutical Lin-Gang Special Area.